Quantitative Models in Life Science Business From Value Creation to Business Processes /
This open access book explores the field of life science business from a multidisciplinary perspective. Applying statistical, mathematical, game-theoretic, and data science tools to pharmaceutical and biotechnology business endeavors, the book describes value creation, value maintenance, and value r...
Saved in:
| Corporate Author: | |
|---|---|
| Other Authors: | , , |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Cham :
Springer International Publishing : Imprint: Springer,
2023.
|
| Edition: | 1st ed. 2023. |
| Series: | SpringerBriefs in Economics,
|
| Subjects: | |
| Online Access: | Link to Metadata |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000nam a22000005i 4500 | ||
|---|---|---|---|
| 001 | 978-3-031-11814-2 | ||
| 003 | DE-He213 | ||
| 005 | 20240322001548.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 221116s2023 sz | s |||| 0|eng d | ||
| 020 | |a 9783031118142 |9 978-3-031-11814-2 | ||
| 024 | 7 | |a 10.1007/978-3-031-11814-2 |2 doi | |
| 050 | 4 | |a RA410-410.9 | |
| 072 | 7 | |a KCQ |2 bicssc | |
| 072 | 7 | |a BUS070170 |2 bisacsh | |
| 072 | 7 | |a KCVJ |2 thema | |
| 082 | 0 | 4 | |a 338.4761 |2 23 |
| 245 | 1 | 0 | |a Quantitative Models in Life Science Business |h [electronic resource] : |b From Value Creation to Business Processes / |c edited by Jung Kyu Canci, Philipp Mekler, Gang Mu. |
| 250 | |a 1st ed. 2023. | ||
| 264 | 1 | |a Cham : |b Springer International Publishing : |b Imprint: Springer, |c 2023. | |
| 300 | |a IX, 127 p. 25 illus., 13 illus. in color. |b online resource. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a text file |b PDF |2 rda | ||
| 490 | 1 | |a SpringerBriefs in Economics, |x 2191-5512 | |
| 505 | 0 | |a Part I. Value Creation and Managing Intellectual Property in the Life Science Industry -- Chapter 1. Value Creation, Valuation and Business Models in the Pharmaceutical Sector -- Chapter 2. Alternative Licensing Strategies: A Piecewise Deterministic Differential Game -- Chapter 3. Partnership Models for R&D in the Pharmaceutical Industry -- Part II. Modelling Specific Business Processes in the Life Science Industry -- Chapter 4. Pharma Tender Processes: Modelling Auction Outcomes -- Chapter 5. Multi-Echelon Inventory Optimization Using Deep Reinforcement Learning -- Part III. Specialized Quantitative Tools in the Life Science Industry -- Chapter 6. Stochastic Differential Equations in Healthcare -- Chapter 7. Point Processes with Mixed Doubly Stochastic Poisson and Self-Exciting Flavors: An Excursion Into DALY Computations. | |
| 506 | 0 | |a Open Access | |
| 520 | |a This open access book explores the field of life science business from a multidisciplinary perspective. Applying statistical, mathematical, game-theoretic, and data science tools to pharmaceutical and biotechnology business endeavors, the book describes value creation, value maintenance, and value realization in the life sciences as a sequence of processes using the quantitative language of applied mathematics. Written by experts from a variety of fields, the contributions illustrate the shift from a deterministic to a stochastic view of the processes involved, offering a new perspective on life sciences economics. The book covers topics such as valuing and managing intellectual property in life science, licensing in the pharmaceutical business, outsourcing pharmaceutical R&D, and stochastic modelling of a pharmaceutical supply chain. The book will appeal to scholars of economics and the life sciences, as well as to professionals in chemical and pharmaceutical industries. . | ||
| 650 | 0 | |a Medical economics. | |
| 650 | 0 | |a Pharmaceutical chemistry. | |
| 650 | 0 | |a Technological innovations. | |
| 650 | 0 | |a Medicine |x Research. | |
| 650 | 0 | |a Biology |x Research. | |
| 650 | 0 | |a Biotechnology. | |
| 650 | 0 | |a Econometrics. | |
| 650 | 1 | 4 | |a Health Economics. |
| 650 | 2 | 4 | |a Pharmaceutics. |
| 650 | 2 | 4 | |a Economics of Innovation. |
| 650 | 2 | 4 | |a Biomedical Research. |
| 650 | 2 | 4 | |a Biotechnology. |
| 650 | 2 | 4 | |a Quantitative Economics. |
| 700 | 1 | |a Canci, Jung Kyu. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Mekler, Philipp. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Mu, Gang. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 710 | 2 | |a SpringerLink (Online service) | |
| 773 | 0 | |t Springer Nature eBook | |
| 776 | 0 | 8 | |i Printed edition: |z 9783031118135 |
| 776 | 0 | 8 | |i Printed edition: |z 9783031118159 |
| 830 | 0 | |a SpringerBriefs in Economics, |x 2191-5512 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-031-11814-2 |z Link to Metadata |
| 912 | |a ZDB-2-ECF | ||
| 912 | |a ZDB-2-SXEF | ||
| 912 | |a ZDB-2-SOB | ||
| 950 | |a Economics and Finance (SpringerNature-41170) | ||
| 950 | |a Economics and Finance (R0) (SpringerNature-43720) | ||